Mims Expands on the Evaluation of Emavusertib in the TakeAim Leukemia Trial of AML and MDS
Season 10, Episode 16, Feb 26, 08:15 PM
Dr Mims discusses the utility of emavusertib in acute myeloid leukemia and myelodysplastic syndrome and the rationale for the TakeAim Leukemia trial.